What We're Reading: Page 399
Industry reads hand-picked by our editors
Jan 15, 2015
Jan 14, 2015
Jan 13, 2015
Jan 12, 2015
-
Reuters
How one hedge fund manager plans to take on big pharma patents
-
-
-
-
Biogen Idec's novel optical nerve repair therapy shows promise, but only some
-
-
Finally approved: FDA says 'yes' to Impax's Parkinson's drug
-
-
Tensions with pharma run high as UK's Cancer Drugs Fund cuts expenses
-
Novartis seeks FDA approval for two smoker's cough drugs
Jan 09, 2015
-
The first groundbreaking antibiotic in 25 years may literally come out of the ground
-
-
-
Siga ordered to pay $113M to PharmaAthene in smallpox case
-
-
Namenda controversy continues as Actavis awaits court decision
-
-
-
Study reveals no Gardasil-MS link
-
Novartis OTC advertising under fire after Pfizer complaint
Jan 08, 2015
Jan 07, 2015
-
-
UPDATE: Novartis Neupogen biosimilar takes yet another step toward FDA approval
-
-
Minnesota Investment Board will not support Medtronic-Covidien inversion deal
-
-
Moderna raises record $450M from investors with groundbreaking RNA tech
-
Salix CEO Logan becomes second C-suite casualty of inventory spat
-
NIH awards $28 million in grants to unlock mysteries of gene regulation
-
-
J&J and Isis strike $835 million co-development deal
Previous
